LANKENAU INSTITUTE FOR MEDICAL RESEARCH

The organization over time

Each line starts at 100 in 2017, so what you read is the shape rather than the size: 150 means half as much again as 2017, 50 means half. The number beside each label in the key is where it ended.

How it's funded, over time

Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.

Government-grant reliance: 2017 30% · 2018 33% · 2019 32% · 2020 29% · 2021 22% · 2022 24% · 2023 19% · 2024 19% · 2025 18%. Grants only. Government contracts and fees sit inside program revenue.

Surplus & reserves

Operating surplus or deficit each year, and months of liquidity in hand. 9 of the last 9 reported years ran a deficit.

Who funds it, year by year

2017 → 2023: the base narrowed from 7 funders to 6 funders, grant income fell $661k → $566k.

2 of 23 of your funders are donor-advised or pass-through sponsors (tagged DAF) — 2% of grant dollars received. That money is really individual donors directing a sponsor; the institutions to cultivate are the non-DAF funders.

Left out of every figure on this page: $31M from 3 payers (the payer shares this organization's board, largest Lankenau Medical Center Foundation). These are real filings, and they are not money LANKENAU INSTITUTE FOR MEDICAL RESEARCH raised.

From the IRS filings of LANKENAU INSTITUTE FOR MEDICAL RESEARCH’s funders (the co-funder graph). Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

How concentrated its funding is

LANKENAU INSTITUTE FOR MEDICAL RESEARCH has a broad base — no single funder exceeds 22% of grant income, and it takes 4 funders to reach half.

39% of the income these shares are computed over arrives through pass-through sponsors or from payers whose filings do not say what kind of payment it is. Concentration is still measured over all of it, because the money is real; what it does not support is a claim about how many institutions have chosen to fund LANKENAU INSTITUTE FOR MEDICAL RESEARCH.

Largest funder’s share by year: 2017 55% · 2018 36% · 2019 23% · 2020 19% · 2021 34% · 2022 44% · 2023 44% — diversifying over time.

“Effective funders” = inverse Herfindahl index (1 / Σ shareᵢ²) — the number of equal-sized funders that would give the same concentration. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

How long its funders stay

21% of LANKENAU INSTITUTE FOR MEDICAL RESEARCH's funders are still giving 3 years after their first grant; 65% give in more than one year at all.

Share of funders still giving k years after their first recorded grant, pooled across every acquisition cohort. A funder counts as retained in a year only if it made a grant that year. Measured to FY2023, the last fiscal year that has finished arriving — a funder cannot be counted as lapsed in a year most filers have not reached.

Where its funders are

LANKENAU INSTITUTE FOR MEDICAL RESEARCH draws 66% of its grant income from funders outside Pennsylvania, across 7 states in all.

Funder states come from each funder’s own filing. $66k arriving through sponsors registered in 2 states is excluded from the map and the split above: a sponsor holds money on a donor’s behalf, so its registered address would place those dollars somewhere no donor need ever have been. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.